| Product Code: ETC7552163 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India Pruritus Market refers to the market for products and treatments aimed at addressing pruritus, commonly known as itching. Pruritus can be caused by various factors such as skin conditions, allergies, and systemic diseases. The market includes pharmaceutical products like antihistamines, corticosteroids, and topical creams, as well as non-pharmaceutical options such as moisturizers, cooling lotions, and phototherapy devices. The market is driven by the high prevalence of skin disorders in India, including eczema, psoriasis, and allergic reactions, leading to a significant demand for pruritus relief solutions. Key players in the market are focusing on developing innovative products with fewer side effects and improved efficacy to cater to the growing needs of patients suffering from pruritus.
The India pruritus market is witnessing significant growth due to the increasing prevalence of skin disorders and rising awareness about the available treatment options. The market is experiencing a shift towards the adoption of advanced therapies such as topical creams, oral medications, phototherapy, and biologic agents for managing pruritus effectively. There is a growing demand for innovative treatment solutions that offer quick relief from itching symptoms, presenting opportunities for pharmaceutical companies to develop and introduce new products in the market. Additionally, the increasing healthcare expenditure and expanding healthcare infrastructure in India are driving the market growth further. Collaborations between pharmaceutical companies and research institutions for the development of novel therapies are also expected to fuel market expansion in the coming years.
In the India Pruritus Market, several challenges are faced, including limited awareness and understanding of pruritus among the general population and healthcare providers, leading to underdiagnosis and undertreatment of the condition. Additionally, there is a lack of standardized treatment guidelines for pruritus in India, resulting in inconsistent management approaches and suboptimal outcomes for patients. Access to specialized care and medications for pruritus can also be limited in certain regions, further exacerbating the burden on patients. The stigma associated with chronic itching conditions like pruritus may prevent individuals from seeking timely medical help, impacting their quality of life. Overall, addressing these challenges through increased awareness, education, and access to appropriate care is essential for improving the management of pruritus in India.
The India Pruritus Market is primarily driven by factors such as the increasing prevalence of skin disorders, rising awareness about pruritus symptoms and treatment options, growing healthcare infrastructure, and a surge in research and development activities focused on developing innovative therapies. Additionally, the expanding geriatric population and changing lifestyles leading to skin-related issues contribute to the market growth. Furthermore, the availability of over-the-counter medications, increasing disposable income, and advancements in diagnostic technologies are also key drivers shaping the India Pruritus Market. The demand for effective and long-lasting pruritus treatment solutions, coupled with the emphasis on personalized medicine, is expected to fuel market expansion in the coming years.
In India, the government has implemented policies aimed at regulating the pharmaceutical market and ensuring the availability of safe and effective treatments for pruritus, or itching. The Drug Controller General of India (DCGI) oversees the approval and monitoring of pharmaceutical products, including those used in the treatment of pruritus. The government has also taken steps to promote the use of generic drugs to make treatments more affordable and accessible to the general population. Additionally, the Ministry of Health and Family Welfare has introduced initiatives to improve healthcare infrastructure and increase awareness about skin conditions like pruritus. Overall, these policies seek to enhance the quality of care for individuals suffering from pruritus in India.
The India Pruritus Market is expected to witness steady growth in the coming years due to an increasing prevalence of skin disorders, rising awareness about pruritus symptoms, and advancements in healthcare infrastructure. The market is projected to be driven by a growing geriatric population, changing lifestyles leading to skin conditions, and the availability of innovative treatment options. Additionally, the rising disposable income levels and expanding healthcare access in India are likely to contribute to the market`s growth. Pharmaceutical companies focusing on developing new therapies for pruritus management will further propel market expansion. Overall, the India Pruritus Market is anticipated to experience significant growth opportunities in the foreseeable future.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Pruritus Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Pruritus Market Revenues & Volume, 2021 & 2031F |
3.3 India Pruritus Market - Industry Life Cycle |
3.4 India Pruritus Market - Porter's Five Forces |
3.5 India Pruritus Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 India Pruritus Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of skin diseases in India |
4.2.2 Growing awareness about pruritus and its management |
4.2.3 Rising disposable income leading to higher healthcare spending |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in rural areas |
4.3.2 Lack of reimbursement policies for pruritus treatment |
4.3.3 Presence of alternative traditional remedies impacting market growth |
5 India Pruritus Market Trends |
6 India Pruritus Market, By Types |
6.1 India Pruritus Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 India Pruritus Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 India Pruritus Market Revenues & Volume, By Korsuva (Difelikefalin), 2021- 2031F |
6.1.4 India Pruritus Market Revenues & Volume, By Livmarli (Maralixibat), 2021- 2031F |
6.1.5 India Pruritus Market Revenues & Volume, By Bylvay (Odevixibat), 2021- 2031F |
6.1.6 India Pruritus Market Revenues & Volume, By Nemolizumab, 2021- 2031F |
6.1.7 India Pruritus Market Revenues & Volume, By EP547, 2021- 2031F |
6.1.8 India Pruritus Market Revenues & Volume, By Dupilumab, 2021- 2031F |
6.1.9 India Pruritus Market Revenues & Volume, By MC2-25, 2021- 2031F |
6.1.10 India Pruritus Market Revenues & Volume, By MC2-25, 2021- 2031F |
7 India Pruritus Market Import-Export Trade Statistics |
7.1 India Pruritus Market Export to Major Countries |
7.2 India Pruritus Market Imports from Major Countries |
8 India Pruritus Market Key Performance Indicators |
8.1 Number of dermatology clinics offering pruritus treatment |
8.2 Percentage of population seeking medical help for pruritus symptoms |
8.3 Adoption rate of advanced pruritus treatment options |
8.4 Research and development investments in innovative pruritus therapies |
9 India Pruritus Market - Opportunity Assessment |
9.1 India Pruritus Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 India Pruritus Market - Competitive Landscape |
10.1 India Pruritus Market Revenue Share, By Companies, 2024 |
10.2 India Pruritus Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here